Author Question: The patient receives reteplase (Retavase) intravenously (IV). The nurse assesses the patient for ... (Read 11 times)

Collmarie

  • Hero Member
  • *****
  • Posts: 569
The patient receives reteplase (Retavase) intravenously (IV). The nurse assesses the patient for orientation and level of consciousness. The patient's wife asks the nurse why this is being done.
 
  What does the nurse indicate as the reason for the assessment?
  1. The medication can alter fluid balance; this affects orientation and level of consciousness.
  2. The medication can cause bleeding in the brain; this affects orientation and level of consciousness.
  3. The medication causes hypoglycemia; this affects orientation and level of consciousness.
  4. The medication decreases oxygen to the brain; this decreases orientation and level of consciousness.

Question 2

The patient is receiving diltiazem (Cardizem) and wants to know why he developed a headache after taking the medication. What is the best response by the nurse?
 
  1. Diltiazem (Cardizem) causes the blood vessels in your brain to widen; giving you the headache.
  2. Diltiazem (Cardizem) increases prostaglandin synthesis; giving you the headache.
  3. Diltiazem (Cardizem) releases Substance P, activating pain receptors in your brain and giving you the headache.
  4. Diltiazem (Cardizem) causes the blood vessels in your brain to narrow; giving you the headache.



Sweetkitty24130

  • Sr. Member
  • ****
  • Posts: 291
Answer to Question 1

Correct Answer: 2
Rationale: Cerebral hemorrhage is a concern with reteplase (Retavase) therapy; the nurse must assess for changes in mental and neurological status. Reteplase (Retavase) does not decrease oxygen to the brain. Reteplase (Retavase) does not cause hypoglycemia. Reteplase (Retavase) does not alter fluid balance in the body.

Answer to Question 2

Correct Answer: 1
Rationale: Side effects of diltiazem (Cardizem) are generally not serious and are related to vasodilation: headache, dizziness, and edema of the ankles and feet. Side effects of diltiazem (Cardizem) are related to vasodilation, not vasoconstriction. Diltiazem (Cardizem) does not alter prostaglandin synthesis. Diltiazem (Cardizem) does not lead to a release of Substance P.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

Collmarie

  • Hero Member
  • *****
  • Posts: 569
Both answers were spot on, thank you once again




 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Pope Sylvester II tried to introduce Arabic numbers into Europe between the years 999 and 1003, but their use did not catch on for a few more centuries, and Roman numerals continued to be the primary number system.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

For a complete list of videos, visit our video library